Investigation of Protein Biomarkers of Prostate Cancer

This study is ongoing, but not recruiting participants.

Sponsored by:	University of New Mexico
Information provided by:	University of New Mexico
ClinicalTrials.gov Identifier:	NCT00323180

Purpose

This study is looking at biomarkers in prostate cancer.

Condition
Prostate Cancer

MedlinePlus related topics: Cancer Prostate Cancer

Study Type:	Observational
Study Design:	Prospective
Official Title:	Investigation of Protein Biomarkers of Prostate Cancer

Further study details as provided by University of New Mexico:

Study Start Date:	August 2005
Estimated Study Completion Date:	August 2010
Estimated Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)

Detailed Description:

To establish primary culture of epithelial cells isolated from prosatectomy samples
To study biomarkers in prostate cancer

Eligibility

Criteria

Inclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00323180

Locations

United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131

Sponsors and Collaborators

University of New Mexico

Investigators

Principal Investigator:

Marco Bisoffi

University of New Mexico

More Information

Responsible Party:	Universtiy of New Mexico ( Marco Bisoffi; Principal Investigator )
Study ID Numbers:	HRRC 03-376
Study First Received:	May 5, 2006
Last Updated:	October 16, 2008
ClinicalTrials.gov Identifier:	NCT00323180
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 14, 2009